Rehabilitationsstandards für die Anschlussheilbehandlung und allgemeine Rehabilitation von Patienten mit einem Herzunterstützungssystem (VAD – ventricular assist device)

Clinical Research in Cardiology Supplements - Tập 11 - Trang 2-49 - 2016
Detlev Willemsen1, C. Cordes2, B. Bjarnason-Wehrens3, E. Knoglinger4, E. Langheim5, R. Marx6,7, N. Reiss1, T. Schmidt1, A. Workowski1, P. Bartsch1, C. Baumbach8, C. Bongarth9, H. Phillips10, R. Radke11, M. Riedel12, S. Schmidt2, E. Skobel13, C. Toussaint14, J. Glatz5
1Schüchtermann-Klinik, Bad Rothenfelde, Deutschland
2Gollwitzer-Meier-Klinik, Bad Oeynhausen, Deutschland
3Institut für Kreislaufforschung und Sportmedizin, Deutsche Sporthochschule Köln, Köln, Deutschland
4Kirchberg-Klinik, Bad Lauterberg, Deutschland
5Reha-Zentrum Seehof der DRV-Bund, Teltow, Deutschland
6MediClin Fachklinik Rhein/Ruhr, Essen, Deutschland
7Universität Witten/Herdecke, Witten, Deutschland
8Herz- und Gefäßzentrum Bad Bevensen, Bad Bevensen, Deutschland
9Klinik Höhenried, Bernried am Starnberger See, Deutschland
10Reha Parcs Steinhof, Erkrath, Deutschland
11Christiaan-Barnard-Klinik, Dahlen-Schmannewitz, Dahlen, Deutschland
12Klinik Fallingbostel, Bad Fallingbostel, Deutschland
13Rehaklinik „An der Rosenquelle“, Aachen, Deutschland
14m&i Fachklinik Herzogenaurach, Herzogenaurach, Deutschland

Tóm tắt

The increasing use of ventricular assist devices (VADs) in terminal heart failure patients provides new challenges to cardiac rehabilitation physicians. Structured cardiac rehabilitation strategies are still poorly implemented for this special patient group. Clear guidance and more evidence for optimal modalities are needed. Thereby, attention has to be paid to specific aspects, such as psychological and social support and education (e.g., device management, INR self-management, drive-line care, and medication). In Germany, the post-implant treatment and rehabilitation of VAD Patients working group was founded in 2012. This working group has developed clear recommendations for the rehabilitation of VAD patients according to the available literature. All facets of VAD patients’ rehabilitation are covered. The present paper is unique in Europe and represents a milestone to overcome the heterogeneity of VAD patient rehabilitation.

Tài liệu tham khảo

Statistisches Bundesamt Gesundheit. Todesursachen in Deutschland 2012. https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Todesursachen/Todesursachen2120400127004.pdf?__blob=publicationFile. Zugegriffen: 15. Jan 2016 Statistisches Bundesamt Gesundheit. Diagnosedaten der Patienten und Patientinnen in Krankenhäusern (einschl. Sterbe- und Stundenfälle) 2011. https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Krankenhaeuser/DiagnosedatenKrankenhaus2120621117004pdf?__blob=publicationFile. Zugegriffen: 15. Jan 2016 Eurotransplant International Foundation Active heart waiting list (at year-end) in All ET, by year, by country, Report: 3071P_All ET_heart. http://statistics.eurotransplant.org/reportloader.php?report=56893-6141-5853&format=html&download=0, Zugegriffen: 15. Jan 2016 Eurotransplant International Foundation Heart donation, deceased donors in Germany, by year, by allocation phase, Report: 1142P_Germany_heart. http://statistics.eurotransplant.org/reportloader.php?report=55359-6010-5853&format=html&download=0, Zugegriffen: 15. Jan 2016 Beyersdorf F (2009) Heart transplant and artificial heart systems. Dtsch Arztebl Int 106(28–29):469–70 German Society for Thoracic and Cardiovascular Surgery GSTCVS Annual Registry. Survey Period 2014. https://idw-online.de/de/attachmentdata43088.pdf. Zugegriffen: 13. Mai 2015 Kirklin J, Naftel D, Pagani F, Kormos R, Stevenson L, Blume E, Miller M, Timothy Baldwin J, Young J (2014) Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant 33(6):555–564 Franke I (2014) Kreislaufunterstützungssysteme: Auf dem Weg zum Dauereinsatz. Dtsch Arztebl Int 111(1–2):A-31–A-32 Workowski A, Willemsen D (2015) Befragung der kardiologischen Rehabilitationseinrichtungen in Deutschland. Nicht publizierte Statistik (für den AK-VAD). Bad Rothenfelde Corrà U, Pistono M, Mezzani A, Gnemmi M, Tarro Genta F, Caruso R, Giannuzzi P (2011) Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part I: exercise therapy. Monaldi Arch Chest Dis 76(1):27–32 Pistono M, Corrà U, Gnemmi M, Imparato A, Caruso R, Balestroni G, Tarro Genta F, Angelino E, Giannuzzi P (2011) Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part II: long-term therapy. Monaldi Arch Chest Dis 76(3):136–145 Vanhees L, Rauch B, Piepoli M, van Buuren F, Takken T, Borjesson M, Bjarnason-Wehrens B, Doherty P, Dugmore D, Halle M (2012) Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III). Eur J Prev Cardiol 19(6):1333–1356 Feldman D, Pamboukian S, Teuteberg J, Birks E, Lietz K, Moore S, Morgan J, Arabia F, Bauman M, Buchholz H, Deng M, Dickstein M, El-Banayosy A, Elliot T, Goldstein D, Grady K, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte M, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov E, Eduardo Rame J, Russell S, Sorensen E, Sun B, Strueber M, Mangi A, Petty M, Rogers J (2013) The 2013 International Society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 32(2):157–187 AQUA GmbH: Weiterentwicklung des Leistungsbereiches Herztransplantation. Abschlussbericht, Stand: 15. März 2014. https://www.sqg.de/sqg/upload/CONTENT/Themen/Leistungsbereiche/HTX/Abschlussbericht_WE_LB_HTX.pdf. Zugegriffen: 19. Mai 2015 Pinkster I, Burgt B, Janssen D, Veenendaal E (2004) Successful test management. An Integral Approach. Springer, Dordrecht Deutsche Rentenversicherung Bund Anforderungsprofil zur Durchführung der Medizinisch-beruflich orientierten Rehabilitation (MBOR) im Auftrag der Deutschen Rentenversicherung. Stand 2015. http://www.deutsche-rentenversicherung.de/cae/servlet/contentblob/207024/publicationFile/50641/mbor_datei.pdf. Zugegriffen: 13. Juli 2015 Gemeinsamer Bundesausschuss (BA) (2014) Richtlinie des Gemeinamen Bundesausschusses über Leistungen zur medizinischen Rehabilitation. vom 16. März 2004, zuletzt geändert am 17. April 2014. Bundesanzeiger BAnz AT 26. Juni 2014 B4 Collin C (2003) Measurement of disabillity and handicap. In: Greenwood R (Hrsg) Handbook of neurological rehabilitation. Psychology Press, Hove Bundesarbeitsgemeinschaft für Rehabilitation (BAR) (2005) Rahmenempfehlungen zur ambulanten kardiologischen Rehabilitation. http://www.bar-frankfurt.de/fileadmin/dateiliste/publikationen/empfehlungen/downloads/Rahmenempfehlung_kardiologische_Rehabilitation.pdf. Zugegriffen: 7. Juli 2015 Bundesverband Deutscher Privatkrankenanstalten e. V. (2005) Rahmenkonzept zur stationären Rehabilitation bei kardiologischen Erkrankungen. http://www.bdpk.de/media/file/81.Rahmenkonzept_zur_stationaeren_Rehabilitation_bei_kardiologischen_Erkrankungen.pdf. Zugegriffen: 7. Juli 2015 Deutsche Rentenversicherung Bund(2009) Rahmenkonzept zur medizinischen Rehabilitation in der gesetzlichen Rentenversicherung. 3. Auflage. http://www.deutsche-rentenversicherung.de/cae/servlet/contentblob/207036/publicationFile/2127/rahmenkonzept_medizinische_reha.pdf. Zugegriffen: 7. Juli 2015 Deutsche Rentenversicherung Bund Reha-Qualitätssicherung der Deutschen Rentenversicherung: Strukturqualität von Reha-Einrichtungen – Anforderungen der Deutschen Rentenversicherung, 2. überarbeitete und erweiterte Auflage, Juli 2014. http://www.deutsche-rentenversicherung.de/Allgemein/de/Inhalt/3_Infos_fuer_Experten/01_sozialmedizin_forschung/downloads/quali_strukturqualitaet/Broschuere_Strukturanforderungen.pdf?__blob=publicationFile&v=9. Zugegriffen: 15. Jan 2016 Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J, Böttiger B (2010) European resuscitation council guidelines for resuscitation 2010 Section 1. Executive summary. Resuscitation 81(10):1219–1276 Pagani F, Miller L, Russell S, Aaronson K, John R, Boyle A, Conte J, Bogaev R, MacGillivray T, Naka Y, Mancini D, Massey H, Chen L, Klodell C, Aranda J, Moazami N, Ewald G, Farrar D, Frazier O (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54(4):312–321 Fang J (2009) Rise of the machines – left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 361(23):2282–2285 HeartWare® Inc (2009) Heart Ware – Ventrikuläres Unterstützungssystem. Gebrauchsanweisung Slaughter M, Pagani F, McGee E, Birks E, Cotts W, Gregoric I, Howard Frazier O, Icenogle T, Najjar S, Boyce S, Acker M, John R, Hathaway D, Najarian K, Aaronson K (2013) HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 32(7):675–683 Slaughter M, Pagani F, Rogers J, Miller L, Sun B, Russell S, Starling R, Chen L, Boyle A, Chillcott S, Adamson R, Blood M, Camacho M, Idrissi K, Petty M, Sobieski M, Wright S, Myers T, Farrar D (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29(4):S1–S39 Strueber M, O’Driscoll G, Jansz P, Khaghani A, Levy W, Wieselthaler G (2011) Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 57(12):1375–1382 Thoratec Corporation (2008) HeartMate II® LVAS: instructions for use. Thoratec Corporation, Pleasanton HeartWare® Inc. http://www.heartware.com/sites/default/files/fields/library/hvad-handshot-palm-high.jpg. Zugegriffen: 29. Juli 2015 Thoratec Corporation per Mailkontakt zugeschickte und zur Veröffentlichung freigegebene Bilddatei – Reprinted with the permission of Thoratec Corporation. Zugegriffen: 20. August 2015 HeartWare® Inc. per Mailkontakt zugeschickte und zur Veröffentlichung freigegebene Bilddateien. 10.8.2015 HeartWare® Inc. http://www.heartware.com/sites/default/files/fields/library/monitor-with-controller-and-batteries-high.jpg. Zugegriffen: 29. Juli 2015 Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, Nishimura T, Yao A, Hirata Y, Kyo S, Ono M, Nagai R (2011) Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 75(5):1147–1155 Mezzani A, Pistono M, Corrà U, Giordano A, Gnemmi M, Imparato A, Centofanti P, Rinaldi M, Colombo S, Canal E, Giannuzzi P (2014) Systemic perfusion at peak incremental exercise in left ventricular assist device recipients: partitioning pump and native left ventricle relative contribution. IJC Heart Vessels 4:40–45 Myers T, Bolmers M, Gregoric I, Kar B, Frazier O (2009) Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant 28(5):423–427 Ammar K, Umland M, Kramer C, Sulemanjee N, Jan M, Khandheria B, Seward J, Paterick T (2012) The ABCs of left ventricular assist device echocardiography: a systematic approach. Eur Heart J Cardiovasc Imaging 13(11):885–899 Buck T, Breithardt O, Faber L, Fehske W, Flachskampf F, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Tiemann K, Voigt J, Weidemann F, Nixdorff U (2009) Manual zur Indikation und Durchführung der Echokardiographie. Clin Res Cardiol Suppl 4(S1):3–51 Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, Picard M, Roman M, Seward J, Shanewise J, Solomon S, Spencer K, St John Sutton M, Stewart W (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echo 18(12):1440–1463 Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography. A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15(2):167–184 Kirkpatrick J, Wiegers S, Lang R (2010) Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography. Curr Cardiol Rep 12(3):257–264 Rasalingam R, Johnson S, Bilhorn K, Huang P, Makan M, Moazami N, Pérez J (2011) Transthoracic echocardiographic assessment of continuous-flow left ventricular assist devices. J Am Soc Echo 24(2):135–148 Topilsky Y, Maltais S, Oh J, Atchison F, Perrault L, Carrier M, Park S (2011) Focused review on transthoracic echocardiographic assessment of patients with continuous axial left ventricular assist devices. Cardiol Res Pract 2011:1–11 Topilsky Y, Oh J, Atchison F, Shah D, Bichara V, Schirger J, Kushwaha S, Pereira N, Park S (2011) Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echo 24(2):157–169 Stainback RF, Estep JD, Agler DA, Birks EJ, Bremer M, Hung J, Kirkpatrick JN, Rogers JG, Shah NR (2015) Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 28(8):853–909 Martina JR, Westerhof BE, van Goudoever J, Jonge N de, van Lieshout JJ, Lahpor JR, De Mol BAJM (2010) Noninvasive blood pressure measurement by the Nexfin monitor during reduced arterial pulsatility. A feasibility study. ASAIO J 56(3):221–227 Lanier G, Orlanes K, Hayashi Y, Murphy J, Flannery M, Te-Frey R, Uriel N, Yuzefpolskaya M, Mancini D, Naka Y, Takayama H, Jorde U, Demmer R, Colombo P (2013) Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail 6(5):1005–1012 McMurray J, Adamopoulos S, Anker S, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez M, Jaarsma T, Kober L, Lip G, Maggioni A, Parkhomenko A, Pieske B, Popescu B, Ronnevik P, Rutten F, Schwitter J, Seferovic P, Stepinska J, Trindade P, Voors A, Zannad F, Zeiher A, Bax J, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes P, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet L, Avraamides P, Ben Lamin H, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf F, Guida G, Hardman S, Iung B, Merkely B, Mueller C, Nanas J, Nielsen O, Orn S, Parissis J, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847 Scheiderer R, Belde C, Schwab D, Haney C, Praz J (2013) Exercise guidelines for inpatients following ventricular assist device placement: a systematic review of the literature. Cardiopulm Phys Ther J 24(12):35–42 Trappe H, Löllgen H (2000) Leitlinien zur Ergometrie. Z Kardiol 89:821–837 Corrà U, Piepoli MF, Adamopoulos S, Agostoni P, Coats AJS, Conraads V, Lambrinou E, Pieske B, Piotrowicz E, Schmid J-P, Seferović PM, Anker SD, Filippatos G, Ponikowski PP (2014) Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 16(9):929–941 Loyaga-Rendon RY, Plaisance EP, Arena R, Shah K (2015) Exercise physiology, testing, and training in patients supported by a left ventricular assist device. J Heart Lung Transplant 34(8):1005–1016 American Thoracic Society (ATS) (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117 Podsiadlo D, Richardson S (1991) The timed „Up & Go“. A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148 Wonisch M, Hofmann P, Pokan R, Kraxner W, Hödl R, Maier R, Watzinger N, Smekal G, Klein W, Fruhwald F (2003) Spiroergometrie in der Kardiologie – Grundlagen der Physiologie und Terminologie. J Kardiol 10(9):383–390 Fess E (1982) The effect of Jamar dynamometer handle position and test protocol on normal grip strength. J Hand Surg Am 7:308–309 Marschall F, Gail S (2011) Standardisierung eines Testprotokolls zur Bestimmung der isometrischen Maximalkraft. Beweg Gesundh 27(06):226–230 Krabatsch T, Potapov E, Soltani S, Dandel M, Falk V, Knosalla C (2015) Ventrikuläre Langzeitunterstützung mit implantierbaren kontinuierlichen Flusspumpen. Auf dem Weg zum Goldstandard in der Therapie der terminalen Herzinsuffizienz. Herz 40(2):231–239 Vierecke J, Kaufmann F, Schweiger M, Stepanenko A, Dranishnikov N, Lehmkuhl H, Potapov E, Hetzer R, Krabatsch T (2011) Erste Maßnahmen und Verhalten bei Störungen eines Kunstherzsystems. Notfall Rettungsmed 14(8):635–646 Wilson SR, Givertz MM, Stewart GC, Mudge GH (2009) Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 54(18):1647–1659 Garan A, Iyer V, Whang W, Mody K, Yuzefpolskaya M, Colombo P, Te-Frey R, Takayama H, Naka Y, Garan H, Jorde U, Uriel N (2014) Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. ASAIO J 60(3):311–316 Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar C, Karlinosky R, Barold S (2012) Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol 35(11):1377–1383 Slaughter M, Rogers J, Milano C, Russell S, Conte J, Feldman D, Sun B, Tatooles A, Delgado R, Long J, Wozniak T, Ghumman W, Farrar D, Frazier O (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241–2251 Oswald H, Klein G, Strüber M, Gardiwal A (2009) Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg 8(5):579–580 Oswald H, Schultz-Wildelau C, Gardiwal A, Lüsebrink U, König T, Meyer A, Duncker D, Pichlmaier MA, Klein G, Strüber M (2010) Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail 12(6):593–599 Pecha S, Wilke I, Bernhardt A, Hakmi S, Yildirim Y, Steven D, Reichenspurner H, Willems S, Deuse T, Aydin A (2014) Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 25(10):1109–1114 Andersen M, Videbæk R, Boesgaard S, Sander K, Hansen P, Gustafsson F (2009) Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 28(7):733–735 Refaat M, Tanaka T, Kormos R, Mcnamara D, Teuteberg J, Winowich S, London B, Simon M (2012) Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device supported heart failure patients. J Cardiac Fail 18(2):140–145 Enriquez A, Calenda B, Miller M, Anyanwu A, Pinney S (2013) The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol 6(4):668–674 Cantillon D, Tarakji K, Kumbhani D, Smedira N, Starling R, Wilkoff B (2010) Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm 7(4):466–471 Garan A, Yuzefpolskaya M, Colombo P, Morrow J, Te-Frey R, Dano D, Takayama H, Naka Y, Garan H, Jorde U, Uriel N (2013) Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices. J Am Coll Cardiol 61(25):2542–2550 Pettit S, Petrie M, Connelly D, Japp A, Payne J, Haj-Yahia S, Gardner R (2012) Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. Eur J Heart Fail 14(7):696–702 Muratsu J, Hara M, Mizote I, Asano Y, Sakata Y, Saito S, Matsumiya G, Sawa Y, Komuro I (2011) The impact of cardiac resynchronization therapy in an end-stage heart failure patient with a left ventricular assist device as a bridge to recovery. Int Heart J 52(4):246–247 Ambardekar A, Lowery C, Allen L, Cannon A, Cleveland J, Lindenfeld J, Brieke A, Sauer W (2010) Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Cardiac Fail 16(4):327–331 Moss A, Schuger C, Beck C, Brown M, Cannom D, Daubert J, Estes N, Greenberg H, Hall W, Huang D, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283 Reibis RK, Kamke W, Langheim E, Völler H (2010) Rehabilitation von Patienten mit Herzschrittmachern und Kardioverter-Defibrillatoren: Empfehlungen zu Training, Physiotherapie und beruflicher Wiedereingliederung. Dtsch Med Wochenschr 135(15):759–764 Volkmann H (2004) Störbeeinflussung von implantierten Herzschrittmachern im medizinischen Bereich. Herzschr Elektrophys 15(1):65–72 Meyer AL, Mohr F-W, Strüber M (2014) Update der kardialen Assistenzsysteme. Z Herz- Thorax- Gefäßchir 28(3):185–195 Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M (2010) Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 3(6):675–681 Potapov EV, Stepanenko A, Krabatsch T, Hetzer R (2011) Managing long-term complications of left ventricular assist device therapy. Curr Opin Cardiol 26(3):237–244 Teuteberg JJ, Kormos RL, Lockard K, Kunz N, Allen C, Scanlon A, Weaver S, Hall D, Bermudez C, Shullo MA (2013) Management of anticoagulation in patients with mechanical circulatory support using a physician-based versus a pharmacist directed anticoagulation clinic-based strategy. J Heart Lung Transplant 32(4):S294–S295 Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012) Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther 134(2):189–199 Rossi M, Serraino GF, Jiritano F, Renzulli A (2012) What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg 15(4):733–740 Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O’Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309(12):1268–1277 Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost A, Engel P, Kramer MR, Serdarevic-Pehar M, Layton GR, Sitbon O, Badesch DB (2014) Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension. J Heart Lung Transplant 33(7):689–697 Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, Mathai SC, Thiemann DR, Hassoun PM, Girgis RE, Orens JB, Shah AS, Yuh D, Conte JV, Champion HC (2008) PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 1(4):213–219 Milano C, Simeone A (2013) Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev 18(1):35–53 Hannan M, Husain S, Mattner F, Danziger-Isakov L, Drew R, Corey GR, Schueler S, Holman W, Lawler L, Gordon S, Mahon NG, Herre J, Gould K, Montoya J, Padera R, Kormos R, Conte J, Mooney M (2011) Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 30(4):375–384 Pauwaa S, Bhat G (2011) Ventricular assist device-specific infections. In: Shuhaiber J (Hrsg) Ventricular assist devices. InTechOpen, Rijeka Holman WL, Rayburn BK, McGiffin DC, Foley BA, Benza RL, Bourge RC, Pinderski LJ, Kirklin JK (2003) Infection in ventricular assist devices. Prevention and treatment. Ann Thorac Surg 75(6):S48–S57 Sharma V, Deo S, Stulak J, Durham L, Daly R, Park S, Baddour L, Mehra K, Joyce L (2012) Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 94(5):1381–1386. Nienaber J, Kusne S, Riaz T, Walker R, Baddour L, Wright AJ, Park S, Vikram H, Keating M, Arabia F, Lahr B, Sohail M (2013) Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 57(10):1438–1448 Ruscher C (2014) Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 57(6):695–732 Garatti A, Giuseppe B, Russo C, Marco O, Ettore V (2007) Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. J Heart Lung Transplant 9(26):956–959 World Health Organization (2001) International classification of functioning, disability and health. ICF. WHO, Geneva Knoglinger E (2008) WHO-Klassifikation ICF: Grundlagen und Anwendbarkeit in der kardiologischen Rehabilitation. Herzmedizin 25:36–42 Cieza A, Ewert T, Ustün TB, Chatterji S, Kostanjsek N, Stucki G (2004) Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med (44 Suppl):9–11 Wildner M, Quittan M, Portenier L, Wilke S, Boldt C, Stucki G, Kostanjsek N, Grill E (2005) ICF Core Set for patients with cardiopulmonary conditions in early post-acute rehabilitation facilities. Disabil Rehabil 27(7–8):397–404 Deutsches Institut für Medizinische Dokumentation und Information (DIMDI) (2005)WHO-Kooperationszentrum für das System Internationaler Klassifikationen: Internationale Klassifikation der Funktionsfähigkeit, Behinderung und Gesundheit. http://www.dimdi.de/dynamic/de/klassi/downloadcenter/icf/endfassung/. Zugegriffen: 18. Mai 2015 Schüle K, Huber G (2000) Grundlagen der Sporttherapie. Prävention, ambulante und stationäre Rehabilitation, 1. Aufl. Urban & Fischer, München Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G (2007) Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115(19):2497–2505 Rogers J, Aaronson K, Boyle A, Russell S, Milano C, Pagani F, Edwards B, Park S, John R, Conte J, Farrar D, Slaughter M (2010) Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55(17):1826–1834 Jung MH, Gustafsson F (2015) Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant 34(4):489–496 Humphrey R (1997) Exercise physiology in patients with left ventricular assist devices. J Cardpulm Rehabil 17(2):73–75 Piña I (2010) Cardiac rehabilitation in heart failure: a brief review and recommendations. Curr Cardiol Rep 12(3):223–229 Wells C (2013) Physical therapist management of patients with ventricular assist devices: key considerations for the acute care physical therapist. Phys Ther 93(2):266–278 Hayes K, Leet A, Bradley S, Holland A (2012) Effects of exercise training on exercise capacity and quality of life in patients with a left ventricular assist device: a preliminary randomized controlled trial. J Heart Lung Transplant 31(7):729–734 Karapolat H, Engin C, Eroglu M, Yagdi T, Zoghi M, Nalbantgil S, Durmaz B, Kirazlı Y, Ozbaran M (2013) Efficacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients. Transplant Proc 45(9):3381–3385 Kohli H, Canada J, Arena R, Tang D, Peberdy M, Harton S, Flattery M, Doolin K, Katlaps G, Hess M, Kasirajan V, Shah K (2011) Exercise blood pressure response during assisted circulatory support: comparison of the total artifical heart with a left ventricular assist device during rehabilitation. J Heart Lung Transplant 30(11):1207–1213 Laoutaris I, Dritsas A, Adamopoulos S, Manginas A, Gouziouta A, Kallistratos M, Koulopoulou M, Voudris V, Cokkinos D, Sfirakis P (2011) Benefits of physical training on exercise capacity, inspiratory muscle function, and quality of life in patients with ventricular assist devices long-term postimplantation. Eur J Cardiovasc Prev Rehabil 18(1):33–40 Marko C, Danzinger G, Käferbäck M, Lackner T, Müller R, Zimpfer D, Schima H, Moscato F (2014) Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices. Eur J Prev Cardiol 22(11):1378–1384 Nissinoff J, Tian F, Therattil M, Salvarrey R, Lee S (2011) Acute inpatient rehabilitation after left ventricular assist device implantation for congestive heart failure. PM R 3(6):586–589 Kugler C, Malehsa D, Schrader E, Tegtbur U, Guetzlaff E, Haverich A, Strueber M (2012) A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support. Eur J Cardiothorac Surg 42(6):1026–1032 Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ (2014) Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy? J Cardiopulm Rehabil Prev 34(4):233–240 Compostella L, Russo N, Setzu T, Bottio T, Compostella C, Tarzia V, Livi U, Gerosa G, Iliceto S, Bellotto F (2015) A practical review for cardiac rehabilitation professionals of continuous-flow left ventricle assist devices: historical and current perspectives. J Cardiopulm Rehabil Prev 35(5):301–311 Workowski A (2015) Kardiologische Rehabilitation von Patienten mit einem Herzunterstützungssystem. Dissertation, Deutsche Sporthochschule Köln Workowski A, Bartsch P, Stuhr H, Willemsen D, Bjarnason-Wehrens B (2014) Resistance training in patients with an intracorporal ventricular assist device (VAD) of the third generation during phase II cardiac rehabilitation (CR). Eur J Prev Cardiol 21:6 Piepoli M, Conraads V, Corrà U, Dickstein K, Francis D, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid J, Anker S, Solal A, Filippatos G, Hoes A, Gielen S, Giannuzzi P, Ponikowski P (2011) Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Europ J Heart Fail 13(4):347–357 Tagermann M, Russel N (2009) Standard of care: physical therapy management of the patient with a ventricular assist device. http://www.brighamandwomens.org/Patients_Visitors/pcs/rehabilitationservices/Physical%20Therapy%20Standards%20of%20Care%20and%20Protocols/Cardiac%20-%20VAD%20SOC%20.pdf. Zugegriffen: 13. Mai 2015 Roefe D, Schulz U (2014) „Ventricular-assist-device“-Koordination. Z Herz- Thorax- Gefäßchir 28(5):327–331 Gemeinsamer Bundesausschuss (2011) Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Heilmitteln in der vertragsärztlichen Versorgung: Heilmittel-Richtlinie. www.g-ba.de/downloads/62-492-532/HeilM-RL_2011-05-19_bf.pdf. Zugegriffen: 5. März 2015 Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD (1993) Performance profiles of the functional independence measure. Am J Phys Med Rehabil 72(2):84–89 Internationale Vereinigung für Assessment in der Rehabilitation (IVAR) (Hrsg) FIM – Funktionale Selbständigkeitsmessung. Manual. 1. Version. Straubing 1997 Shepherd J, Wilding C (2006) Occupational therapy for people with ventricular assist devices. Aust Occup Therap J 53(1):47–49 Albert W, Bittner A, Kiekbusch S, Buschtöns C, Gehringer A, Kinzel S, Hetzer R (2002) Das Kunstherz – eine extreme psychische Belastungssituation? Z Herz Thorax Gefasschir 16(1):I/110–I/119 Bunzel B, Roethy W, Znoj H, Laederach-Hofmann K (2008) Psychological consequences of life-saving cardiac surgery in patients and partners: measurement of emotional stress by the Impact of Event Scale. Stress Health 24(5):351–363 Mapelli, D.; Cavazzana, A.; Cavalli, C.; Bottio, T.; Tarzia, V.; Gerosa, G.; Volpe, B. R.: Clinical psychological and neuropsychological issues with left ventricular assist devices (LVADs). In: Annals of cardiothoracic surgery 3 (2014) 5, S. 480–89. MacIver J, Ross H (2012) Quality of life and left ventricular assist device support. Circulation 126(7):866–874 Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443 Brouwers C, Denollet J, De Jonge N, Caliskan K, Kealy J, Pedersen S (2011) Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail 4(6):714–723 Kugler C, Malehsa D, Tegtbur U, Guetzlaff E, Meyer A, Bara C, Haverich A, Strueber M (2011) Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant 30(2):204–210 Ladwig K, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, Fritzsche K, Haass M, Jordan J, Jünger J, Kindermann I, Köllner V, Kuhn B, Scherer M, Seyfarth M, Völler H, Waller C, Herrmann-Lingen C (2013) Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie. Kardiologe 7(1):7–27 Petrucci R, Rogers J, Blue L, Gallagher C, Russell S, Dordunoo D, Jaski B, Chillcott S, Sun B, Yanssens T, Tatooles A, Koundakjian L, Farrar D, Slaughter M (2012) Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transplant 31(1):27–36 Kirklin J, Naftel D, Kormos R, Stevenson L, Pagani F, Miller M, Timothy Baldwin J, Young J (2013) Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32(2):141–156 Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ (2014) Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 63(17):1751–1757 Herrmann-Lingen C, Buss U, Snaith R (2011) HADS-D – Hopital Anxiety and Depression Scale – Deutsche Version. 3. aktualisierte und neu normierte Aufl. Hogrefe, Bern Bullinger M, Kirchberger I (1998) Medical outcomes study Short-Form General Health Survey SF-36 manual (German version). Göttingen Graf J-M, Claes C, Greiner W, Uber A (1998) Die deutsche Version des EuroQol-Fragebogens. J Public Health 6(1):3–20 Rabin R, Charro F de (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337–343 Faller H, Steinbüchel T, Schowalter M, Spertus JA, Störk S, Angermann CE (2005) Der Kansas City Cardiomyopathy Questionnaire (KCCQ) – ein neues krankheitsspezifisches Messinstrument zur Erfassung der Lebensqualität bei chronischer Herzinsuffizienz – Psychometrische Prüfung der deutschen Version. Psychother Psychosom Med Psychol 55(3–4):200–208 Green C, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire. A new health status measure for heart failure. J Am Coll Cardiol 35(5):1245–1255 Middel B, Bouma J, Jongste M de, van Sonderen E, Niemeijer MG, Crijns H, van den Heuvel W (2001) Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Clin Rehabil 15(5):489–500 Quittan M, Wiesinger GF, Crevenna R, Nuhr MJ, Posch M, Hülsmann M, Müller D, Pacher R, Fialka-Moser V (2001) Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. J Rehabil Med 33(4):182–186 Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW (2007) Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116(5):497–505 Dang N, Topkara V, Kim B, Lee B, Remoli R, Naka Y (2005) Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg 130(5):e3–e4 John R, Lietz K, Schuster M, Naka Y, Rao V, Mancini DM, Rose EA, Smith CR, Oz MC, Edwards NM, Itescu S (2003) Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125(3):578–591 Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S, Nakatani T, Kitamura S (2009) Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 28(5):428–433 Evans W, Morley J, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch W, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker S (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799 Ng MFY (2010) Cachexia – an intrinsic factor in wound healing. Int Wound J 7(2):107–113 Anker SD, Negassa A, Coats AJS, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors. An observational study. Lancet 361(9363):1077–1083 Lietz K, John R, Burke EA, Ankersmit JH, McCue JD, Naka Y, Oz MC, Mancini DM, Edwards NM (2001) Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation1. Transplantation 72(2):277–283 McMurray J, Petrie M, Swedberg K, Komajda M, Anker S, Gardner R (2009) Heart failure. In: Camm A, Lüscher T, Serruys P (Hrsg) The ESC textbook of cardiovascular medicine. Oxford University Press, Rotterdam Sandek A, Doehner W, Anker SD, Haehling S von (2009) Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care 12(4):384–391 Montgomery T, Cohen A, Garnick J, Spadafore J, Boldea E (2012) Nutrition assessment, care, and considerations of ventricular assist device patients. Nutr Clin Pract 27(3):352–362 Akashi YJ, Springer J, Anker SD (2005) Cachexia in chronic heart failure. Prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2(4):198–203 Pasini E, Opasich C, Pastoris O, Aquilani R (2004) Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure. Am J Cardiol 93(8A):41A–43A Nestlé Nutrition Institute: Mini Nutritional Assessment. MNA®. http://www.mnaelderly.com/forms/mini/mna_mini_german.pdf. Zugegriffen: 26. Juni 2015 Deutsche Adipositas-Gesellschaft (DAG) e. V., Deutsche Diabetes Gesellschaft (DDG), Deutsche Gesellschaft für Ernährung (DGE) e. V., Deutsche Gesellschaft für Ernährungsmedizin (DGEM) e. V. (2014): Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“, Version 2.0 (April 2014). http://www.awmf.org/uploads/tx_szleitlinien/050-001l_S3_Adipositas_Prävention_Therapie_2014-11.pdf. Zugegriffen: 26. Juni 2015 Creutzberg EC, Wouters EFM, Mostert R, Pluymers RJ, Schols AMWJ (2003) A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 124(5):1733–1742 Slaughter MS, Pappas P, Tatooles A (2003) Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist device. ASAIO J 49(5):611–612 Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313 Yancy C, Jessup M, Bozkurt B, Butler J, Casey D, Drazner M, Fonarow G, Geraci S, Horwich T, Januzzi J, Johnson M, Kasper E, Levy W, Masoudi F, McBride P, McMurray J, Mitchell J, Peterson P, Riegel B, Sam F, Stevenson L, Tang W, Tsai E, Wilkoff B (2013) 2013 AHA guideline for the management of heart failure. J Am Coll Cardiol 62(16):e147–e239 Habbu A, Lakkis NM, Dokainish H (2006) The obesity paradox: fact or fiction? Am J Cardiol 98(7):944–948 Musci M, Loforte A, Potapov EV, Krabatsch T, Weng Y, Pasic M, Hetzer R (2008) Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg 86(4):1236–1242 Klodell CT, Staples ED, Aranda JM, Schofield RS, Hill JA, Pauly DF, Beaver TM (2006) Managing the post-left ventricular assist device patient. Congest Heart Fail 12(1):41–45 MTBASA - Medizinisch-Technische Beratungsstelle der Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation. http://www.mtbasa.de. Zugegriffen: 15. Jan 2016 Hiestand B (2009) Circulatory assist devices in heart failure patients. Heart Fail Clin 5(1):55–62 Bundesärztekammer (BÄK); Arbeitsgemeinschaft der Deutschen Ärztekammern; Kassenärztliche Bundesvereinigung (KBV); Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2009): Nationale Versorgungsleitlinie „Chronische Herzinsuffizienz“ – Langfassung, 1. Aufl. Version 7. 2009, zuletzt geändert: August 2013. http://www.leitlinien.de/mdb/downloads/nvl/herzinsuffizienz/herzinsuffizienz-1aufl-vers7-lang.pdf. Zugegriffen: 21. Mai 2015 Universität Leipzig – Herzzentrum (2015) Kunstherz-Patientenführerschein Corra U, Pistono M, Piepoli MF, Giannuzzi P (2012) Ventricular assist device patients on the horizon of cardiovascular prevention and rehabilitation. Can we convert challenges into opportunities? Eur J Prev Cardiol 19(3):490–493 Egerod I, Overgaard D (2012) Taking a back seat: support and self-preservation in close relatives of patients with left ventricular assist device. Eur J Cardiovasc Nurs 11(4):380–387 Nguyen E, Stein J (2013) Functional outcomes of adults with left ventricular assist devices receiving inpatient rehabilitation. PM R 5(2):99–103 Ambardekar A, Cannon A, Cleveland J, Brieke A, Lindenfeld J (2011) Driving with a driveline: a survey of current practice patterns for allowing a patient supported with a left ventricular assist device to drive. J Heart Lung Transplant 30(10):1204–1205 Thoratec Corporation (2011) Heart Mate II community living manual: your guide to successful LVAS patient discharges. Thoracec Corp, Pleasanton Emani S, O’Keefe C, Wissman S, MacBrair K, White L, Hasan A, Sai-Sudhakar C, Sun B (2011) 190 Driver’s education: a single center experience on the incidence and safety of driving with LVADS. J Heart Lung Transplant 30(4):S70 Emani S, Pagani F, Eckman P, Gordon R, Brisco M, Klodell C, Mandras S, Hasan A, Sai-Sudhakar C, Sun B (2013) Hit the road: a multicenter evaluation of driving with LVADs. J Heart Lung Transplant 32(4):S98 Klein H, Krämer A, Pieske B, Trappe H, De Vries H (2010) Fahreignung bei kardiovaskulären Erkrankungen. Kardiologe 4(6):441–473 Golka K, Hengstler JG (Hrsg) (2011) Verkehrsmedizin – arbeitsmedizinische Aspekte. Orientierungshilfe für Praxis, Klinik und Betrieb; Schwerpunktthema Jahrestagung DGAUM 2010. ecomed, Heidelberg Madea B, Abel R (Hrsg) (2012) Verkehrsmedizin. Fahreignung, Fahrsicherheit, Unfallrekonstruktion; mit 128 Tabellen. Deutscher Ärzte-Verlag, Köln Baskett R, Crowell R, Freed D, Giannetti N, Simpson C (2012) Canadian Cardiovascular Society focused position statement update on assessment of the cardiac patient for fitness to drive: fitness following left ventricular assist device implantation. Can J Cardiol 28(2):137–140 Gräcmann N, Albrecht M Begutachtungsleitlinien zur Kraftfahreignung. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit Heft M 115, gültig ab 1. Mai 2014. Bergisch Gladbach 2014 Coyle L, Martin M, Kurien S, Graham J, Gallagher C, Silver M, Slaughter M (2008) Destination therapy: safety and feasibility of national and international travel. ASAIO J 54(2):172–176 Lufthansa Operation Center, m. 0.-5., mündliche Information MedStar Heart Institute Air Travel Letter Template. http://www.mylvad.com/content/lvad-travel-tips. Zugegriffen: 21. Mai 2015 Park S, Milano C, Tatooles A, Rogers J, Adamson R, Steidley D, Ewald G, Sundareswaran K, Farrar D, Slaughter M (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5(2):241–248 Bunzel B, Laederach-Hofmann K, Wieselthaler G, Roethy W, Wolner E (2007) Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant 26(4):384–389 Dev S, Abernethy A, Rogers J, O’Connor C (2012) Preferences of people with advanced heart failure – a structured narrative literature review to inform decision making in the palliative care setting. Am Heart J 164(3):313–319.e5 Bruce C, Smith M, McCullough L (2013) Clarification of the intent of ventricular assist devices before patient consent. J Thorac Cardiovasc Surg 145(6):1423–1425 Bramstedt K, Chalfant A, Wright C (2007) Emergency consults in the setting of transplant medicine. Dilemmas for social workers and bioethicists. Prog Transplant 17(1):36–39 Bruce C, Bhimaraj A, Smith M (2014) Revisiting surrogate consent for ventricular assist device placement. Ann Thorac Surg 97(3):747–749 Brush S, Budge D, Alharethi R, McCormick A, MacPherson J, Reid B, Ledford I, Smith H, Stoker S, Clayson S, Doty J, Caine W, Drakos S, Kfoury A (2010) End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant 29(12):1337–1341 Tanner C, Fromme E, Goodlin S (2011) Ethics in the treatment of advanced heart failure: palliative care and end-of-life issues. Congest Heart Fail 17(5):235–240 Adler E, Goldfinger J, Kalman J, Park M, Meier D (2009) Palliative care in the treatment of advanced heart failure. Circulation 120(25):2597–2606 Kini V, Kirkpatrick J (2013) Ethical challenges in advanced heart failure. Curr Opin Support Palliat Care 7(1):21–28 Swetz K, Freeman M, AbouEzzeddine O, Carter K, Boilson B, Ottenberg A, Park S, Mueller P (2011) Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 86(6):493–500 Gerhard C et al (2012) Arbeitspapier der AG Nicht-Tumorpatienten – Palliativversorgung bei Herzinsuffizienz. Z Palliativmed 13(02):61–63 Jaarsma T, Beattie J, Ryder M, Rutten F, McDonagh T, Mohacsi P, Murray S, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker S, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11(5):433–443 Bruce CR, Brody B, Majumder MA (2013) Ethical dilemm as surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction. Methodist Debakey Cardiovasc J 9(1):11–14 Rizzieri A, Verheijde J, Rady M, McGregor J (2008) Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med 3(1):20 Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztebl 108(7):A346–A348 Bramstedt K (2008) Destination nowhere: a potential dilemma with ventricular assist devices. ASAIO J 54(1):1–2 Mueller P, Swetz K, Freeman M, Carter K, Crowley M, Severson C, Park S, Sulmasy D (2010) Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 85(9):791–797 Gafford E, Luckhardt A, Swetz K (2013) Deactivation of a left ventricular assist device at the end of life #269. J Palliat Med 16(8):980–982